Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
198
|
Mon, 8/8/2022,
2:00 PM -
3:50 PM
|
CC-204A
|
|
Innovations in Patient-Focused Clinical Trials — Contributed Papers
|
|
Biopharmaceutical Section
|
|
Chair(s): John Han, J&J
|
|
2:05 PM
|
Likelihood-Based Inferences for Hybrid Trials Incorporating Patient's Treatment Choice
Rouba Chahine, RTI International; Inmaculada A Aban, The University of Alabama at Birmingham
|
|
2:20 PM
|
Innovative Basket Trails Design Using BIC (Bayesian Hierarchical Mixed Model, Patient Information, Clustering)
Chenyang Duan, Oregon State University ; Zheyu Liu, Bayer; Christoph Neumann, Bayer
|
|
2:35 PM
|
Use and Potential Challenges of Consumer Wearable Devices in Clinical Trials
T. Paulette Ceesay, Merck & Co; Vladimir Svetnik, Merck Research Labs
|
|
2:50 PM
|
Comparison of Estimand Strategies and Analysis Methods on Patient-Reported Outcome (PRO) Endpoint
Saijuan (Sandra) Zhang, Bristol Myers Squibb
|
|
3:05 PM
|
A Comparison of K-Means and Consensus Clustering Algorithms in the Analysis of Wearable and Biosensor Data
Vanja Vlajnic, Bayer; Steve Simske, Colorado State University
|
|
3:20 PM
|
Utility of Computerized Adaptive Testing for Measuring Endpoints in Clinical Trials
Fraser Bocell, US FDA/CDRH; Weimeng Weng, US FDA/CDER; Xin Yuan, US FDA/CDER; Kevin Weinfurt, Duke University
|
|
3:35 PM
|
Approaches for Understanding Treatment Effects with Health Measures: The Meaningfulness of Expected Scores Versus Expected Differences in Scores
Laura Lee Johnson, U.S. Food and Drug Administration; Fraser Bocell, US FDA/CDRH; Monica Morell, U.S. Food and Drug Administration; Kevin Weinfurt, Duke University
|
|
